Free Trial
OTCMKTS:BIOVF

Swedish Orphan Biovitrum (BIOVF) Stock Price, News & Analysis

Swedish Orphan Biovitrum logo
$51.05 0.00 (0.00%)
As of 11/13/2026

About Swedish Orphan Biovitrum Stock (OTCMKTS:BIOVF)

Advanced

Key Stats

Today's Range
$51.05
▼
$51.05
50-Day Range
$42.80
▼
$51.05
52-Week Range
$35.25
▼
$51.05
Volume
968 shs
Average Volume
280 shs
Market Capitalization
$18.17 billion
P/E Ratio
23.42
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Moderate Buy

Company Overview

Swedish Orphan Biovitrum AB, known as Sobi, is a Swedish biopharmaceutical company focused on developing and providing treatments for rare and other serious diseases. Its work centers on hematology, immunology and specialized medicines for conditions with limited treatment options.

Sobi’s portfolio includes therapies for blood disorders such as hemophilia, as well as treatments for rare inflammatory and immune-related conditions. The company also develops and commercializes medicines for other rare diseases, working with research and commercial partners where appropriate.

The company was formed in 2010 when Biovitrum acquired Swedish Orphan and adopted the Swedish Orphan Biovitrum name. Based in Sweden, Sobi serves patients through operations and partnerships across Europe, North America and other international markets.

AI Generated. May Contain Errors.

Receive BIOVF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Swedish Orphan Biovitrum and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BIOVF Stock News Headlines

Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.tc pixel
See More Headlines

BIOVF Stock Analysis - Frequently Asked Questions

Swedish Orphan Biovitrum's stock was trading at $35.25 at the beginning of 2026. Since then, BIOVF shares have increased by 44.8% and is now trading at $51.05.

Swedish Orphan Biovitrum (OTCMKTS:BIOVF) released its quarterly earnings results on Tuesday, April, 28th. The company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.38 by $0.07. The company earned $755.76 million during the quarter, compared to the consensus estimate of $749.76 million. Swedish Orphan Biovitrum had a net margin of 20.67% and a trailing twelve-month return on equity of 17.92%.

Shares of BIOVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Swedish Orphan Biovitrum investors own include Millicom International Cellular (TIGO), Novo Nordisk A/S (NVO), Oscar Health (OSCR), Cynata Therapeutics (CYYNF), Semafo (SMF), EnQuest (ENQ) and Marks and Spencer Group (MKS).

Company Calendar

Today
11/15/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:BIOVF
CIK
N/A
Fax
N/A
Employees
1,900
Year Founded
2010

Profitability

EPS (Trailing Twelve Months)
$2.01
Trailing P/E Ratio
23.42
Forward P/E Ratio
15.42
P/E Growth
N/A
Net Income
$48.85 million
Net Margins
20.67%
Pretax Margin
4.68%
Return on Equity
17.92%
Return on Assets
9.30%

Debt

Debt-to-Equity Ratio
0.20
Current Ratio
0.88
Quick Ratio
0.55

Sales & Book Value

Annual Sales
$2.89 billion
Price / Sales
6.30
Cash Flow
$4.57 per share
Price / Cash Flow
11.16
Book Value
$10.83 per share
Price / Book
4.71

Miscellaneous

Outstanding Shares
356,000,000
Free Float
N/A
Market Cap
$18.17 billion
Optionable
Not Optionable
Beta
0.48

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (OTCMKTS:BIOVF) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners